Takeo Fujimoto

585 total citations
32 papers, 388 citations indexed

About

Takeo Fujimoto is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Takeo Fujimoto has authored 32 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Takeo Fujimoto's work include Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (11 papers) and Retinoids in leukemia and cellular processes (6 papers). Takeo Fujimoto is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (11 papers) and Retinoids in leukemia and cellular processes (6 papers). Takeo Fujimoto collaborates with scholars based in Japan, United States and South Korea. Takeo Fujimoto's co-authors include Masahito Tsurusawa, N Katano, Makoto Niwa, Yasuhiko Kaneko, Akira Sugawara, Tasuke Konno, Atsushi Sato, Masue Imaizumi, Kazuie Iinuma and Akira Kakizuka and has published in prestigious journals such as Blood, Cancer and The Journal of Pediatrics.

In The Last Decade

Takeo Fujimoto

32 papers receiving 381 citations

Peers

Takeo Fujimoto
Francesca Vendemini Italy
F Krizsa Hungary
Mary Papaioannou United Kingdom
Il-Kwon Lee South Korea
Maryam Behfar Iran
J. G. Smith United Kingdom
Maria Dassi Italy
P Lyn United States
Gradimir Janković Serbia
Vivi M. Srivastava India
Francesca Vendemini Italy
Takeo Fujimoto
Citations per year, relative to Takeo Fujimoto Takeo Fujimoto (= 1×) peers Francesca Vendemini

Countries citing papers authored by Takeo Fujimoto

Since Specialization
Citations

This map shows the geographic impact of Takeo Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Fujimoto more than expected).

Fields of papers citing papers by Takeo Fujimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Fujimoto. The network helps show where Takeo Fujimoto may publish in the future.

Co-authorship network of co-authors of Takeo Fujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Fujimoto. A scholar is included among the top collaborators of Takeo Fujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Fujimoto. Takeo Fujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwata, Atsuko, et al.. (2001). OSTEOSARCOMA AS A SECOND MALIGNANCY AFTER TREATMENT FOR NEUROBLASTOMA. Pediatric Hematology and Oncology. 18(7). 465–469. 5 indexed citations
2.
Fujimoto, Takeo, et al.. (2000). SQUAMOUS CELL CARCINOMA OF THE TONGUE AS A SECOND MALIGNANCY IN A PATIENT PREVIOUSLY TREATED FOR OSTEOSARCOMA. Pediatric Hematology and Oncology. 17(5). 421–424. 2 indexed citations
3.
Fujimoto, Takeo, et al.. (1999). UNUSUAL LATE EXTRAPULMONARY METASTASIS IN OSTEOSARCOMA. Pediatric Hematology and Oncology. 16(6). 545–549. 9 indexed citations
4.
Tsurusawa, Masahito, et al.. (1998). BCL-2 Expression and Prognosis in Childhood Acute Leukemia. Pediatric Hematology and Oncology. 15(2). 143–155. 13 indexed citations
5.
Takitani, Kimitaka, Hiroshi Tamai, Takao Morinobu, et al.. (1995). Pharmacokinetics of All‐trans Retinoic Acid in Pediatric Patients with Leukemia. Japanese Journal of Cancer Research. 86(4). 400–405. 15 indexed citations
6.
Takitani, Kimitaka, Hiroshi Tamai, Takao Morinobu, et al.. (1995). 4-Oxo Retinoic Acid for Refractory Acute Promyelocytic Leukemia in Children with All-Trans Retinoic Acid Therapy.. Journal of Nutritional Science and Vitaminology. 41(4). 493–498. 6 indexed citations
7.
8.
Takaue, Yoichi, Arata Watanabe, Tatsuo Murakami, et al.. (1994). High‐dose chemotherapy and blood stem cell autografts for children with first relapsed acute lymphoblastic leukemia: A pilot study of the children's cancer and leukemia study group of Japan (CCLSG). Medical and Pediatric Oncology. 23(1). 20–25. 10 indexed citations
9.
10.
Shimizu, Hiroyuki & Takeo Fujimoto. (1990). Susceptibility of NB‐I Neuroblastoma Cells to Tumoricidal Activity of Monocytes Activated by γ‐Interferon. Japanese Journal of Cancer Research. 81(10). 1021–1025. 2 indexed citations
11.
Shimizu, Hiroyuki, et al.. (1990). Intramedullary Neutrophil Phagocytosis by Histiocytes in Autoimmune Neutropenia of Infancy. Acta Haematologica. 84(4). 201–203. 3 indexed citations
12.
Tsurusawa, Masahito, Makoto Niwa, N Katano, & Takeo Fujimoto. (1990). Methotrexate Cytotoxicity as Related to Irreversible S Phase Arrest in Mouse L1210 Leukemia Cells. Japanese Journal of Cancer Research. 81(1). 85–90. 18 indexed citations
13.
Tsurusawa, Masahito, Yasuhiko Kaneko, N Katano, et al.. (1989). Flow cytometric evidence for minimal residual disease and cytological heterogeneities in acute lymphoblastic leukemia with severe hypodiploidy. American Journal of Hematology. 32(1). 42–49. 8 indexed citations
14.
15.
Onouchi, Zenshiro, et al.. (1988). QS pattern in the right precordial leads of a child with extensive myocardial fibrosis following myocarditis. Pediatric Cardiology. 9(3). 167–169. 1 indexed citations
16.
Tanaka, Jun, et al.. (1985). Reduced Citrovorum Factor Rescue for High-Dose Methotrexate Therapy in Childhood Malignancies. PubMed. 2(1). 77–86. 10 indexed citations
17.
Fujimoto, Takeo, et al.. (1985). Prognostic Factors in Children with Acute Lymphoblastic Leukemia — Part II: Multivariate Analysis —. Japanese Journal of Clinical Oncology. 15(1). 13–23. 5 indexed citations
18.
Fujimoto, Takeo, et al.. (1983). 小児ｎｏｎ‐Ｈｏｄｇｋｉｎ'ｓリンパしゅのｍｅｔｈｏｔｒｅｘａｔｅ大量療法の長期治療成績とｐｈａｒｍａｃｏｋｉｎｅｔｉｃｓ. 24(2). 96–103. 1 indexed citations
19.
Tanaka, Tetsuro, et al.. (1979). [Unusual complications of a malignant fibrous histiocytoma and leukemic infiltrations in the peritoneal cavity in a child during remission of leukemia (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(1). 97–103. 2 indexed citations
20.
Miyazaki, Sumio, et al.. (1978). Cranial irradiation and lymphocyte subpopulations in acute lymphocytic leukemia. The Journal of Pediatrics. 92(5). 785–786. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Vendemini Breakdown of academic impact, for papers by F Krizsa Breakdown of academic impact, for papers by Mary Papaioannou Breakdown of academic impact, for papers by Il-Kwon Lee Breakdown of academic impact, for papers by Maryam Behfar Breakdown of academic impact, for papers by J. G. Smith Breakdown of academic impact, for papers by Maria Dassi Breakdown of academic impact, for papers by P Lyn Breakdown of academic impact, for papers by Gradimir Janković Breakdown of academic impact, for papers by Vivi M. Srivastava
Rankless by CCL
2026